U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H25ClN2O4S
Molecular Weight 484.995
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of SAMIXOGREL

SMILES

OC(=O)CCC\C=C(/C1=CC=C(CCNS(=O)(=O)C2=CC=C(Cl)C=C2)C=C1)C3=CC=CN=C3

InChI

InChIKey=LGHLGTHRJNIRCA-ZXKDJJQISA-N
InChI=1S/C25H25ClN2O4S/c26-22-11-13-23(14-12-22)33(31,32)28-17-15-19-7-9-20(10-8-19)24(5-1-2-6-25(29)30)21-4-3-16-27-18-21/h3-5,7-14,16,18,28H,1-2,6,15,17H2,(H,29,30)/b24-5+

HIDE SMILES / InChI

Description

Boehringer Ingelheim developed samixogrel as thromboxane A2 receptor antagonists. This drug participated in clinical trials for the treatment patients with diabetic complications, thrombosis, and unstable angina pectoris. However, all these studies were discontinued.

Originator

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Name Type Language
SAMIXOGREL
INN  
INN  
Official Name English
samixogrel [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
NCI_THESAURUS C471
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID701009931
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
EVMPD
SUB10437MIG
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
PUBCHEM
6436053
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
FDA UNII
5MB73H1ADH
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
NCI_THESAURUS
C73214
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
CAS
133276-80-9
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
SMS_ID
100000084050
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
INN
7222
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
ChEMBL
CHEMBL277689
Created by admin on Fri Dec 15 16:15:44 GMT 2023 , Edited by admin on Fri Dec 15 16:15:44 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of SAMIXOGREL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966